on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has disclosed its position in Mural Oncology plc under Irish Takeover Panel Rules. As of June 26, 2025, Vanguard holds 772,915 of Mural Oncology's $0.01 ordinary shares, representing a 4.48% interest. This follows Rule 8.3 of the Irish Takeover Panel Act, 1997.
The notification shows that there have been no relevant cash-settled or stock-settled derivative transactions by Vanguard in Mural Oncology securities. Additionally, no indemnity or other arrangements exist related to these securities.
The disclosure reveals a recent sale activity by Vanguard, involving 48 ordinary shares at $2.48 per share. This form does not entail any other party to the offer nor includes agreements influencing voting rights. The document confirms no need for a Supplemental Form 8.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news